fluorodeoxyglucose f18 has been researched along with Neurofibromatoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlawat, S; Baig, A; Blakeley, JO; Fayad, LM; Jacobs, MA | 1 |
| Graham, MM; Kubo, A; Nishitani, H; Otsuka, H | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Neurofibromatoses
| Article | Year |
|---|---|
Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Multimodal Imaging; Neurilemmoma; Neurofibromatoses; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Whole Body Imaging | 2016 |
FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report.
Topics: Adult; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Male; Neurofibromatoses; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Subtraction Technique; Tomography, X-Ray Computed | 2005 |